Company · Private
clock.bio
Uses genome-wide CRISPR screens in stem cells to discover factors that control cellular rejuvenation, aiming to convert screen hits into therapeutics.
Listing
Private
Ticker
—
Headquarters
Cambridge, UK
Founded
2021
Technology
CRISPR screening for rejuvenation factors
Category
Longevity thesis
Systematic, unbiased screening of the whole genome can surface rejuvenation mechanisms that hypothesis-driven reprogramming has missed.
Programmes
- Rejuvenation factor platformDiscovery
Stem-cell rejuvenation factor screens
Reference information for research context only. It is not a rating, a valuation or investment advice. Published developments appear in the News archive.